Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
BJUI Compass|February 19, 2024
Low PSA radiographic disease progression on C11-choline PETAhmed M Mahmoud, Mohamed E Ahmed, A Tuba Kendi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 20, 2023
Evaluation of Hepatotoxicity from Peptide Receptor Radionuclide Therapy in Patients with Gastroenteropancreatic Neuroendocrine Tumors and a Very High Liver Tumor BurdenDenise A Gococo-Benore, Justin Kuhlman, Ephraim E Parent, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 25, 2025
Outcomes of Peptide Receptor Radionuclide Therapy with <sup>177</sup>Lu-DOTATATE in Patients with Metastatic Pheochromocytoma and ParagangliomaGokce Belge Bilgin, Brian J Burkett, Cem Bilgin, et al.
The Journal of Urology|November 9, 2022
Metastasis-directed Therapy Without Androgen Deprivation Therapy in Solitary Oligorecurrent Prostate CancerJack R Andrews, Mohamed E Ahmed, Vidit Sharma, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 2024
Neurologic Symptoms After <sup>177</sup>Lu-Prostate-Specific-Membrane Antigen-617 Therapy: A Single-Center ExperienceGokce Belge Bilgin, Brian J Burkett, Cem Bilgin, et al.
Journal of the American College of Radiology : JACR|November 6, 2019
ACR Appropriateness Criteria® Clinically Suspected Vascular Malformation of the Extremities, Piotr Obara, Justin McCool, et al.
Radiology. Imaging Cancer|July 21, 2023
A Review of Theranostics: Perspectives on Emerging Approaches and Clinical AdvancementsBrian J Burkett, David J Bartlett, Patrick W McGarrah, et al.
Cancers|March 14, 2026
PSA Zero Radiographic Disease Progression on PSMA PET/CTAhmed M Mahmoud, Carter Day, Eman E Ahmed, et al.
European Journal of Radiology|January 20, 2016
Is there a role for PET/CT parameters to differentiate thyroid cartilage invasion from penetration?A Tuba Kendi, Amanda Corey, Kelly R Magliocca, et al.
Pageof 9